Who are Sight Sciences, Inc.'s main suppliers?

Sight Sciences, Inc. (SGHT) key suppliers include: DEERFIELD-CAMPBELL-LLC, Johnson & Johnson, Johnson & Johnson. View the full supplier network at chainsifter.com/chain/SGHT.

Who are Sight Sciences, Inc.'s major customers?

Sight Sciences, Inc. (SGHT) key customers include: ALCON-INC, ALCON-RESEARCH-LLC, ALCON-VISION-LLC, IVANTIS-INC, ASCS and 4 more. View the full customer network at chainsifter.com/chain/SGHT.

What sector is Sight Sciences, Inc. in?

Sight Sciences, Inc. (SGHT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

SGHT Supply Chain: Sight Sciences, Inc. Supplier List & 15 Relationships

3Suppliers

9Customers

3Debt Items

20Related Chains

Sight Sciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
DEERFIELD-CAMPBELL-LLC	DEERFIELD-CAMPBELL-LLC	90%	The Second Amendment amends that certain Multi-Tenant Space Lease, dated February 5, 2021, and that certain Commencement Date/Acceptance Agreement, dated August 1, 2021, between the Company and Lesso…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from SGHT graph: cialize products for eye conditions. Notable competitors with approved MIGS products include Glaukos, Alcon, AbbVie, N…
JNJ	Johnson & Johnson	72%	cialize products for eye conditions. Notable competitors with approved MIGS products include Glaukos, Alcon, AbbVie, New World Medical, and Nova Eye Medical Limited. Notable competitors with approved…

Sight Sciences, Inc. Customers

Ticker	Name	Confidence	Evidence
ALCON-INC	ALCON-INC	92%	The Company had asserted that Alcon’s sale of the Hydrus® Microstent ("Hydrus") infringed three of the Company’s patents.
ALCON-RESEARCH-LLC	ALCON-RESEARCH-LLC	92%	The Company had asserted that Alcon’s sale of the Hydrus® Microstent ("Hydrus") infringed three of the Company’s patents.
ALCON-VISION-LLC	ALCON-VISION-LLC	92%	The Company had asserted that Alcon’s sale of the Hydrus® Microstent ("Hydrus") infringed three of the Company’s patents.
IVANTIS-INC	IVANTIS-INC	92%	The Company had asserted that Alcon’s sale of the Hydrus® Microstent ("Hydrus") infringed three of the Company’s patents.
ASCS	ASCS	90%	We currently derive the majority of our U.S. revenue from the sale of our OMNI and SION products to ASCs and HOPDs
ECPS	ECPS	90%	We currently derive the majority of our U.S. revenue from the sale of our TearCare products to ECPs
HOPDS	HOPDS	90%	We currently derive the majority of our U.S. revenue from the sale of our OMNI and SION products to ASCs and HOPDs
JNJ	Johnson & Johnson	72%	cialize products for eye conditions. Notable competitors with approved MIGS products include Glaukos, Alcon, AbbVie, New World Medical, and Nova Eye Medical Limited. Notable competitors with approved…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from SGHT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from SGHT graph: cialize products for eye conditions. …

Sight Sciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
SGHT-DEBT-12501	Warrants outstanding: 0	90%	xbrl warrant detail from xbrl 2025-12-31.
SGHT-DEBT	Debt stack $41.8M	90%	Market cache reports total debt of $41.8M.
SGHT-DEBT-12502	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-09-30.

Sight Sciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Sight Sciences, Inc..

Sight Sciences, Inc. Ownership

Holder	Name	Confidence	Evidence
SGHT-OWNER-LONG-FOCUS-CAPITAL-MANAGEMENT-LL	Long Focus Capital Management, LLC	90%	13F overlay lists Long Focus Capital Management, LLC as top holder; 113 tracked holders.

Sight Sciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
REPL	Replimune Group, Inc.	100.00	2
ALEC	Alector, Inc.	100.00	2
ENGN	enGene Therapeutics Inc.	100.00	2
RCUS	Arcus Biosciences, Inc.	100.00	2
OBIO	Orchestra BioMed Holdings, Inc.	100.00	2
KURA	Kura Oncology, Inc.	100.00	2
SVRA	Savara Inc.	100.00	2
CMPS	COMPASS Pathways plc	100.00	2
MDGL	Madrigal Pharmaceuticals, Inc.	100.00	2
PHGE	BiomX Inc.	100.00	2
JNJ	Johnson & Johnson	100.00	1	['customer', 'supplier']
MAZE	Maze Therapeutics, Inc.	100.00	2
VRDN	Viridian Therapeutics, Inc.	100.00	2
BCYC	Bicycle Therapeutics plc	100.00	2
DYN	Dyne Therapeutics, Inc.	100.00	2
IRON	Disc Medicine, Inc.	100.00	2
ALT	Altimmune, Inc.	100.00	2
HOPDS	HOPDS	60.75	1	['receiving']
ECPS	ECPS	60.75	1	['receiving']
ASCS	ASCS	60.75	1	['receiving']

Sight Sciences, Inc. Supply Chain